EWTX

EDGEWISE THERAPEUTICS INC

EWTX·28036F105·US·Common Stock·Healthcare - Biotechnology-Activist

EWTX (EDGEWISE THERAPEUTICS INC) is held by 123 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($341M), BlackRock, Inc. ($268.4M), FMR LLC ($223M). Net institutional sentiment: Mixed.

123
Holders
(9 Elite)
$2.4B
Total Value
63% (128)
Consensus
81 buying - 47 selling
13F: Insider & Congress: Updated regularly
EWTX

Smart Money Verdict

View all
Loading verdict
Held by 123 funds
9 elite

Who's Trading

Source dates: Price Aug 21, 2026 · Insiders Aug 14, 2026 · Activists Aug 14, 2026 · Congress none

ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP3.4%Aug 14, 2026
ActivistPBParadigm BioCapital Advisors LP9.5%Aug 14, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.7.8%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
8.4M(-19.5%)$341M3.0%+150.58%
0
Increased
6.6M(+2.1%)$268.4M0.0%+65.73%
31
Increased
5.5M(+439.7%)$223M0.0%+17.41%
49
Increased
4.7M(+5.6%)$192.1M1.1%+98.82%
51
Increased
3.9M(+1.9%)$156.9M0.0%+52.18%
31
Decreased
3.7M(-43.7%)$150.4M0.8%+181.24%
0
Increased
2.2M(+21.5%)$88.3M0.0%+120.15%
36
Decreased
1.9M(-13.2%)$79.2M0.0%+96.88%
0
Increased
1.8M(+6.5%)$74.3M0.0%+171.63%
32
Increased
2.1M(+23.0%)$66.7M0.0%+54.75%
36
Increased
1.6M(+17.4%)$63.3M0.0%+67.11%
34
Increased
1.3M(+51.6%)$50.9M0.0%+40.95%
41
Decreased
1.1M(-6.6%)$46.3M0.0%+174.91%
0
Decreased
1.1M(-1.8%)$45.8M0.0%+140.29%
0
Increased
902,870(+14.4%)$36.7M0.0%+113.95%
33
Increased
786,456(+41.1%)$32M0.0%+36.97%
38
Increased
671,270(+16.4%)$27.3M0.0%+113.73%
33
Decreased
647,926(-21.6%)$26.3M0.0%+110.22%
0
Increased
620,532(+4.1%)$25.2M0.0%+173.81%
30
Decreased
599,469(-4.8%)$24.4M0.0%+100.62%
0

Showing 1-20 of 132

1 / 7
EWTXEWTXEDGEWISE THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used